SIRT3 has been reported as a tumor suppressor in studies of various human cancers by triggering metabolic reprogramming that promotes tumorigenesis (27, 45, 46, 47, 48), of which EC is of particular interest to clinicians because it is the most common solid tumor and the leading cause of cancer death. Here, SIRT3 is linked to neoplasm.